{{Drugbox
| verifiedrevid = 444760513
| IUPAC_name = 4-[2-(5-nitro-1''H''-imidazol-1-yl)ethyl]morpholine
| image = Nimorazole.svg
| width = 160

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|nimorazole}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number = 6506-37-2
| ATC_prefix = P01
| ATC_suffix = AB06
| ATC_supplemental =  {{ATCvet|P51|AA06}}
| PubChem = 23009
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 469ULX0H4G
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07352
| ChemSpiderID = 21533

<!--Chemical data-->
| chemical_formula =  
| C=9 | H=14 | N=4 | O=3 
| molecular_weight = 226.23 g/mol
| smiles = C1COCCN1CCN2C=NC=C2[N+](=O)[O-]
| StdInChI = 1S/C9H14N4O3/c14-13(15)9-7-10-8-12(9)2-1-11-3-5-16-6-4-11/h7-8H,1-6H2
| StdInChIKey = MDJFHRLTPRPZLY-UHFFFAOYSA-N
}}

'''Nimorazole''' ([[International Nonproprietary Name|INN]]) is a [[nitroimidazole]] [[anti-infective]].<ref>{{Cite journal 
| last1 = Roy | first1 = R. B. 
| last2 = Laird | first2 = S. M. 
| last3 = Heasman | first3 = L. 
| title = Treatment of trichomoniasis in the female. A comparison of metronidazole and nimorazole 
| journal = The British Journal of Venereal Diseases 
| volume = 51 
| issue = 4 
| pages = 281–284 
| year = 1975 
| pmid = 1098732 
| pmc = 1046566
}}</ref> It is also being investigated for the treatment of [[head and neck cancer]].<ref>{{Cite journal 
| doi = 10.1016/S0167-8140(02)00284-0 
| last1 = Henk | first1 = J. M. 
| last2 = Bishop | first2 = K. 
| last3 = Shepherd | first3 = S. F. 
| title = Treatment of head and neck cancer with CHART and nimorazole: Phase II study 
| journal = Radiotherapy and Oncology 
| volume = 66 
| issue = 1 
| pages = 65–70 
| year = 2003 
| pmid = 12559522
}}</ref><ref>{{ClinicalTrialsGov|NCT01507467|IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck}}</ref>

==References==
{{reflist}}

{{Agents against amoebozoa}}
{{Androgenics}}
{{Estrogenics}}

[[Category:Aromatase inhibitors]]
[[Category:Nitroimidazole antibiotics]]
[[Category:Antiprotozoal agents]]
[[Category:Morpholines]]

{{antiinfective-drug-stub}}